For example, in colorectal carcinoma (CRC) cell lines inhibition of NO/PKG/extracellular-signal-regulated kinases (ERK)-signaling mediated by the PKG-inhibitor KT5823 reduced migration and invasion in both scratch wound and modified Boyden chamber assays [55]. This evidence concerns the gene PRKG1 and colorectal carcinoma.